Статті в журналах з теми "DltX"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "DltX".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Poyart, Claire, Marie Cécile Lamy, Claire Boumaila, Franz Fiedler, and Patrick Trieu-Cuot. "Regulation of d-Alanyl-Lipoteichoic Acid Biosynthesis in Streptococcus agalactiae Involves a Novel Two-Component Regulatory System." Journal of Bacteriology 183, no. 21 (November 1, 2001): 6324–34. http://dx.doi.org/10.1128/jb.183.21.6324-6334.2001.
Повний текст джерелаDebabov, Dmitri V., Michael Y. Kiriukhin, and Francis C. Neuhaus. "Biosynthesis of Lipoteichoic Acid inLactobacillus rhamnosus: Role of DltD ind-Alanylation." Journal of Bacteriology 182, no. 10 (May 15, 2000): 2855–64. http://dx.doi.org/10.1128/jb.182.10.2855-2864.2000.
Повний текст джерелаBeeh, K. M., O. Kornmann, J. Lill, and R. Buhl. "Induced sputum cell profiles in lung transplant recipients with or without chronic rejection: correlation with lung function." Thorax 56, no. 7 (July 1, 2001): 557–60. http://dx.doi.org/10.1136/thx.56.7.557.
Повний текст джерелаWood, B. McKay, John P. Santa Maria, Leigh M. Matano, Christopher R. Vickery, and Suzanne Walker. "A partial reconstitution implicates DltD in catalyzing lipoteichoic acid d-alanylation." Journal of Biological Chemistry 293, no. 46 (September 20, 2018): 17985–96. http://dx.doi.org/10.1074/jbc.ra118.004561.
Повний текст джерелаDu, Liqin, and Yu Luo. "Thiolation-enhanced substrate recognition by D-alanyl carrier protein ligase DltA from Bacillus cereus." F1000Research 3 (May 13, 2014): 106. http://dx.doi.org/10.12688/f1000research.4097.1.
Повний текст джерелаDavidsen, Jesper Rømhild, Hans Henrik Lawaetz Schultz, Daniel Pilsgaard Henriksen, Martin Iversen, Anna Kalhauge, Jørn Carlsen, Michael Perch, Ole Graumann, and Christian B. Laursen. "Lung Ultrasound in the Assessment of Pulmonary Complications After Lung Transplantation." Ultraschall in der Medizin - European Journal of Ultrasound 41, no. 02 (November 9, 2018): 148–56. http://dx.doi.org/10.1055/a-0783-2466.
Повний текст джерелаLee, In-Gyun, Chiman Song, Seoyeong Yang, Hanul Jeon, Jingyeong Park, Hye-Jin Yoon, Hookang Im, Sung-Min Kang, Hyun-Jong Eun, and Bong-Jin Lee. "Structural and functional analysis of the D-alanyl carrier protein ligase DltA from Staphylococcus aureus Mu50." Acta Crystallographica Section D Structural Biology 78, no. 4 (March 16, 2022): 424–34. http://dx.doi.org/10.1107/s2059798322000547.
Повний текст джерелаKoprivnjak, Tomaz, Vid Mlakar, Lindsey Swanson, Benedicte Fournier, Andreas Peschel, and Jerrold P. Weiss. "Cation-Induced Transcriptional Regulation of the dlt Operon of Staphylococcus aureus." Journal of Bacteriology 188, no. 10 (May 15, 2006): 3622–30. http://dx.doi.org/10.1128/jb.188.10.3622-3630.2006.
Повний текст джерелаKlein, Uwe, Waheedullah Karzai, Frank Bloos, Mathias Wohlfarth, Reiner Gottschall, Harald Fritz, Michael Gugel, and Albrecht Seifert. "Role of Fiberoptic Bronchoscopy in Conjunction with the Use of Double-lumen Tubes for Thoracic Anesthesia." Anesthesiology 88, no. 2 (February 1, 1998): 346–50. http://dx.doi.org/10.1097/00000542-199802000-00012.
Повний текст джерелаZhong, Wei, Roberto Bugarini, Ling Wang, Cynthia Basu, and Darrin M. Beaupre. "Rethinking about the dose limiting toxicities (DLTs): They can be equivocal!" Journal of Clinical Oncology 37, no. 15_suppl (May 20, 2019): 3064. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.3064.
Повний текст джерелаMthethwa, Sthembile, and Morne Pretorius. "Academic and Skills Credentialing Using Distributed Ledger Technology (DLT) and W3C Standards: Technology Assessment." International Conference on Intelligent and Innovative Computing Applications 2022 (December 31, 2022): 170–82. http://dx.doi.org/10.59200/iconic.2022.019.
Повний текст джерелаKiriukhin, Michael Y., and Francis C. Neuhaus. "d-Alanylation of Lipoteichoic Acid: Role of the d-Alanyl Carrier Protein in Acylation." Journal of Bacteriology 183, no. 6 (March 15, 2001): 2051–58. http://dx.doi.org/10.1128/jb.183.6.2051-2058.2001.
Повний текст джерелаSpatafora, Grace A., Megan Sheets, Rebecca June, David Luyimbazi, Katherine Howard, Robin Hulbert, Daron Barnard, Mariam el Janne, and Michael C. Hudson. "Regulated Expression of the Streptococcus mutans dltGenes Correlates with Intracellular Polysaccharide Accumulation." Journal of Bacteriology 181, no. 8 (April 15, 1999): 2363–72. http://dx.doi.org/10.1128/jb.181.8.2363-2372.1999.
Повний текст джерелаSoltani, Reza, Marzia Zaman, Rohit Joshi, and Srinivas Sampalli. "Distributed Ledger Technologies and Their Applications: A Review." Applied Sciences 12, no. 15 (August 6, 2022): 7898. http://dx.doi.org/10.3390/app12157898.
Повний текст джерелаCostello, Brian Addis, Yingwei Qi, Mitesh J. Borad, George P. Kim, Donald W. Northfelt, Charles Erlichman, and Steven R. Alberts. "Phase I trial of everolimus, gemcitabine and cisplatin for patients with solid tumors refractory to standard therapy." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): e13052-e13052. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.e13052.
Повний текст джерелаJha, Sachin, and Jesse M. Ehrenfeld. "Double Lumen Tubes: Usage and Performance by Frequent and Infrequent Users." ISRN Anesthesiology 2011 (November 1, 2011): 1–4. http://dx.doi.org/10.5402/2011/586592.
Повний текст джерелаMehlis, Katja, Elena Bierwirth, Katsiaryna Laryionava, Friederike Mumm, Pia Heussner, and Eva C. Winkler. "Late decisions about treatment limitation in patients with cancer: empirical analysis of end-of-life practices in a haematology and oncology unit at a German university hospital." ESMO Open 5, no. 5 (October 2020): e000950. http://dx.doi.org/10.1136/esmoopen-2020-000950.
Повний текст джерелаShin, Hyejin, Jung-Eun Ha, Dae Young Zang, Sung-Hyun Kim, Young Rok Do, Won Sik Lee, Soo-Hyun Kim, et al. "Clinical Response Evaluation Toward Individualizing the Starting Dose of Dasatinib in Asian Patients with Chronic Myeloid Leukemia." Blood 136, Supplement 1 (November 5, 2020): 6. http://dx.doi.org/10.1182/blood-2020-140626.
Повний текст джерелаHunaiti, Ziad. "Digital Learning Technologies." International Journal of Handheld Computing Research 8, no. 2 (April 2017): 41–50. http://dx.doi.org/10.4018/ijhcr.2017040103.
Повний текст джерелаZimmermann, Tanja. "End-of-Life: Patientinnen und Patienten rechtzeitig einbinden." Kompass Onkologie 8, no. 2 (2021): 84–85. http://dx.doi.org/10.1159/000516879.
Повний текст джерелаZimmermann, Tanja. "End-of-Life: Patientinnen und Patienten rechtzeitig einbinden." Kompass Pneumologie 9, no. 6 (2021): 308–9. http://dx.doi.org/10.1159/000519230.
Повний текст джерелаZimmermann, Tanja. "End-of-Life: Patientinnen und Patienten rechtzeitig einbinden." Kompass Dermatologie 9, no. 3 (2021): 134–35. http://dx.doi.org/10.1159/000517944.
Повний текст джерелаNurgazina, Jamilya, Udsanee Pakdeetrakulwong, Thomas Moser, and Gerald Reiner. "Distributed Ledger Technology Applications in Food Supply Chains: A Review of Challenges and Future Research Directions." Sustainability 13, no. 8 (April 9, 2021): 4206. http://dx.doi.org/10.3390/su13084206.
Повний текст джерелаMatsuo, Miki, Yuichi Oogai, Fuminori Kato, Motoyuki Sugai, and Hitoshi Komatsuzawa. "Growth-phase dependence of susceptibility to antimicrobial peptides in Staphylococcus aureus." Microbiology 157, no. 6 (June 1, 2011): 1786–97. http://dx.doi.org/10.1099/mic.0.044727-0.
Повний текст джерелаCoupri, Delphine, Aurélie Budin-Verneuil, Axel Hartke, Abdellah Benachour, Loïc Léger, Thierry Lequeux, Emmanuel Pfund та Nicolas Verneuil. "Genetic and pharmacological inactivation of d-alanylation of teichoic acids sensitizes pathogenic enterococci to β-lactams". Journal of Antimicrobial Chemotherapy 74, № 11 (24 липня 2019): 3162–69. http://dx.doi.org/10.1093/jac/dkz322.
Повний текст джерелаInnocenti, Federico, Richard L. Schilsky, Jacqueline Ramírez, Linda Janisch, Samir Undevia, Larry K. House, Soma Das, et al. "Dose-Finding and Pharmacokinetic Study to Optimize the Dosing of Irinotecan According to the UGT1A1 Genotype of Patients With Cancer." Journal of Clinical Oncology 32, no. 22 (August 1, 2014): 2328–34. http://dx.doi.org/10.1200/jco.2014.55.2307.
Повний текст джерелаInnocenti, Federico, Ravi Salgia, Jacqueline Ramirez, Linda A. Janisch, Samir D. Undevia, Larry House, Soma Das, et al. "A genotype-directed study to optimize dosing of irinotecan according to the UGT1A1 genotype." Journal of Clinical Oncology 31, no. 15_suppl (May 20, 2013): 2570. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.2570.
Повний текст джерелаRami, Avina, Steven G. DuBois, and Kevin M. Campbell. "Reporting and impact of subsequent cycle toxicities in oncology phase I clinical trials." Journal of Clinical Oncology 41, no. 16_suppl (June 1, 2023): 3149. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.3149.
Повний текст джерелаLedwaba, Lehlogonolo P. I., Gerhard P. Hancke, Sherrin J. Isaac, and Hein S. Venter. "Smart Microgrid Energy Market: Evaluating Distributed Ledger Technologies for Remote and Constrained Microgrid Deployments." Electronics 10, no. 6 (March 18, 2021): 714. http://dx.doi.org/10.3390/electronics10060714.
Повний текст джерелаPark, Jee Soo, Kyo Chul Koo, Doo Yong Chung, Sun Il Kim, Jeongho Kim, Cheol Kyu Oh, Tae Nam Kim, et al. "Visceral Adiposity as a Significant Predictor of Sunitinib-Induced Dose-Limiting Toxicities and Survival in Patients with Metastatic Clear Cell Renal Cell Carcinoma." Cancers 12, no. 12 (December 2, 2020): 3602. http://dx.doi.org/10.3390/cancers12123602.
Повний текст джерелаRezaei, Mohsen, Rasoul Ajalloeian, and Mohammad Ghafoori. "Comparison between deformation modulus of rock mass measured by plate jacking and dilatometer tests." Przegląd Naukowy Inżynieria i Kształtowanie Środowiska 26, no. 3 (September 15, 2017): 317–25. http://dx.doi.org/10.22630/pniks.2017.26.3.31.
Повний текст джерелаBurnett, Alan K., David Bowen, Nigel Russell, Steven Knapper, Donald Milligan, Ann E. Hunter, Asim Khwaja, et al. "AC220 (Quizartinib) Can Be Safely Combined With Conventional Chemotherapy In Older Patients With Newly Diagnosed Acute Myeloid Leukaemia: Experience From The AML18 Pilot Trial." Blood 122, no. 21 (November 15, 2013): 622. http://dx.doi.org/10.1182/blood.v122.21.622.622.
Повний текст джерелаCeponis, Tomas, Stanislau Lastovskii, Leonid Makarenko, Jevgenij Pavlov, Kornelijus Pukas, and Eugenijus Gaubas. "Study of Radiation-Induced Defects in p-Type Si1−xGex Diodes before and after Annealing." Materials 13, no. 24 (December 12, 2020): 5684. http://dx.doi.org/10.3390/ma13245684.
Повний текст джерелаUmemura, Yoshie, Wajd Al-Holou, Bernard Marini, Denise Leung, Michelle Kim, Sean Ferris, Larry Junck, et al. "CTNI-35. PHASE 0/1 TRIAL OF MYCOPHENOLATE MOFETIL COMBINED WITH CHEMORADIATION TO OVERCOME TREATMENT RESISTANCE IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA BY TARGETING PURINE METABOLISM." Neuro-Oncology 24, Supplement_7 (November 1, 2022): vii79. http://dx.doi.org/10.1093/neuonc/noac209.300.
Повний текст джерелаTillmanns, Todd D., Mark E. Reed, Melissa C. Privett, Amanda L. Johns, Mark S. Walker, and Arthur C. Houts. "Phase I trial of metronomic oral topotecan in combination with pazopanib utilizing a daily dosing schedule to treat recurrent or persistent gynecologic tumors." Journal of Clinical Oncology 30, no. 15_suppl (May 20, 2012): 5014. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.5014.
Повний текст джерелаWright, Karen, Cassie Kline, Mohamed Abdelbaki, David Ebb, Elias Sayour, Jennifer Elster, Sarah Leary, et al. "CTNI-53. PNOC014: PHASE IB STUDY RESULTS OF DAY101(TOVORAFENIB) FOR CHILDREN WITH LOW-GRADE GLIOMAS (LGGS) AND OTHER RAS/RAF/MEK/ERK PATHWAY-ACTIVATED TUMORS." Neuro-Oncology 24, Supplement_7 (November 1, 2022): vii84. http://dx.doi.org/10.1093/neuonc/noac209.318.
Повний текст джерелаWaterhouse, David Michael, Jonathan Wade Goldman, Ben George, Peter J. O'Dwyer, Moncy Ye, Tianlei Chen, Nataliya Trunova, and Karen Kelly. "Nivolumab (nivo) + nab-paclitaxel (nab-P) + carboplatin (C) in patients (pts) with non-small cell lung cancer (NSCLC): Interim results from a multicenter phase I study." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): 9095. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.9095.
Повний текст джерелаFury, M. G., J. Larkin, S. R. Gerst, P. Sabbatini, J. Konner, M. Orlando, D. F. Tai, T. Goss, C. Aghajanian, and M. L. Hensley. "Phase I study of pemetrexed (P) plus gemcitabine (G) in advanced solid tumors (ST)." Journal of Clinical Oncology 25, no. 18_suppl (June 20, 2007): 14055. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.14055.
Повний текст джерелаVélez, Mónica Perea, Tine L. A. Verhoeven, Christian Draing, Sonja Von Aulock, Markus Pfitzenmaier, Armin Geyer, Ivo Lambrichts, et al. "Functional Analysis of d-Alanylation of Lipoteichoic Acid in the Probiotic Strain Lactobacillus rhamnosus GG." Applied and Environmental Microbiology 73, no. 11 (April 13, 2007): 3595–604. http://dx.doi.org/10.1128/aem.02083-06.
Повний текст джерелаMoehler, Markus H., Alexander Stein, Jorg Trojan, Jens Uwe Marquardt, Julia Quidde, Oliver Waidmann, Arndt Weinmann, et al. "Regorafenib with TAS-102 (REGOTAS) in metastatic colorectal cancer patients who progressed after at least two standard therapies: Efficacy and safety results of a multicenter phase I study (REMETY)." Journal of Clinical Oncology 38, no. 4_suppl (February 1, 2020): 158. http://dx.doi.org/10.1200/jco.2020.38.4_suppl.158.
Повний текст джерелаChakravarthy, A. B., F. Y. Wu, C. D. Blanke, J. D. Berlin, R. D. Beauchamp, H. Choy, and D. Delbeque. "A phase I study of neoadjuvant paclitaxel/radiation in patients with potentially resectable adenocarcinoma of the pancreas." Journal of Clinical Oncology 25, no. 18_suppl (June 20, 2007): 15067. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.15067.
Повний текст джерелаFranklin, Anna, Marco Zecca, Franca Fagioli, Flavio Augusto Luisi, Gregory Song, Ajit Suri, E. Jane Leonard, and Franco Locatelli. "Phase 1 Results from a Phase 1/2 Study to Assess the Safety, Tolerability and Recommended Phase 2 Dose (RP2D) of Brentuximab Vedotin Plus Doxorubicin, Vinblastine and Dacarbazine (A+AVD) in Pediatric Patients (Pts) with Advanced Stage Newly Diagnosed Classical Hodgkin Lymphoma (cHL)." Blood 132, Supplement 1 (November 29, 2018): 1644. http://dx.doi.org/10.1182/blood-2018-99-112488.
Повний текст джерелаGlasspool, Rosalind Margaret, Sarah Patricia Blagden, Michelle Lockley, James Paul, Carol Hopkins, Fiona Thomson, Jennifer Brown, et al. "A phase I trial of the oral hedgehog inhibitor taladegib (LY2940680) in combination with weekly paclitaxel in patients with advanced, solid tumours." Journal of Clinical Oncology 35, no. 15_suppl (May 20, 2017): 2594. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.2594.
Повний текст джерелаLee, S. M., D. Hershman, P. Martin, J. Leonard, and K. Cheung. "Validation of toxicity burden score for use in phase I clinical trials." Journal of Clinical Oncology 27, no. 15_suppl (May 20, 2009): 2514. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.2514.
Повний текст джерелаFox, Elizabeth, Richard Aplenc, Rochelle Bagatell, Meredith K. Chuk, Eva Dombi, Wendy Goodspeed, Anne Goodwin, et al. "A Phase 1 Trial and Pharmacokinetic Study of Cediranib, an Orally Bioavailable Pan–Vascular Endothelial Growth Factor Receptor Inhibitor, in Children and Adolescents With Refractory Solid Tumors." Journal of Clinical Oncology 28, no. 35 (December 10, 2010): 5174–81. http://dx.doi.org/10.1200/jco.2010.30.9674.
Повний текст джерелаSkolnik, Jeffrey M., Jeffrey S. Barrett, Bhuvana Jayaraman, Dimple Patel, and Peter C. Adamson. "Shortening the Timeline of Pediatric Phase I Trials: The Rolling Six Design." Journal of Clinical Oncology 26, no. 2 (January 10, 2008): 190–95. http://dx.doi.org/10.1200/jco.2007.12.7712.
Повний текст джерелаRaymond, Eric, Valérie Boige, Sandrine Faivre, Ger-Jan Sanderink, Olivier Rixe, Laurent Vernillet, Christian Jacques, Michel Gatineau, Michel Ducreux, and Jean-Pierre Armand. "Dosage Adjustment and Pharmacokinetic Profile of Irinotecan in Cancer Patients With Hepatic Dysfunction." Journal of Clinical Oncology 20, no. 21 (November 1, 2002): 4303–12. http://dx.doi.org/10.1200/jco.2002.03.123.
Повний текст джерелаSawyer, Michael B., Mark J. Ratain, Donna Bertucci, Robert P. Smith, Richard L. Schilsky, Nicholas J. Vogelzang, Keith Shulman, Edwin C. Douglass, and Gini F. Fleming. "Phase I Study of an Oral Formulation of ZD9331 Administered Daily for 28 Days." Journal of Clinical Oncology 21, no. 9 (May 1, 2003): 1859–65. http://dx.doi.org/10.1200/jco.2003.01.148.
Повний текст джерелаLong, Si, Yuhang Li, Junying Guo, and Rong Hu. "Effect of the VivaSight double-lumen tube on the incidence of hypoxaemia during one-lung ventilation in patients undergoing thoracoscopic surgery: a study protocol for a prospective randomised controlled trial." BMJ Open 13, no. 4 (April 2023): e068071. http://dx.doi.org/10.1136/bmjopen-2022-068071.
Повний текст джерелаBREITENSTEIN, O. "SCANNING-DLTS." Le Journal de Physique Colloques 50, no. C6 (June 1989): C6–101—C6–110. http://dx.doi.org/10.1051/jphyscol:1989609.
Повний текст джерела